Barts Cancer Institute

Campus shot with BCI QM logo

The Barts Cancer Institute (BCI), part of the Barts and The London School of Medicine and Dentistry, Queen Mary University of London, has one overriding objective, which is to ensure that the research conducted here is relevant to and will impact on cancer patients.

Our seven Centres focus on how to reduce the burden of disease through increasing the chances of survival through early detection and diagnosis; and improve patient survival through the discovery and development of more effective and innovative therapies.

Under the leadership of the Director, Professor Nick Lemoine, and supported by an Executive Board of senior investigators, the BCI provides an academic environment fitting for an internationally recognised, comprehensive cancer centre.